Search
Site Search
Search results.
How TB and COVID-19 compare: an opportunity to integrate both control programmes
Letter to the editors which highlights similarities and differences between TB and COVID-19 – and proposes that control programmes unite to address both conditions.
COVID-19: ensuring continuity of TB services in the private sector
Pakistan has the fifth largest global burden of TB, and in response to COVID-19 a lockdown was imposed on 26 February. TB services were severely disrupted. This threatened to undermine recent gains in private-sector engagement and TB…
Responding to COVID-19: adjusting TB services in a low-burden setting
A letter to the editors in which the Victorian Tuberculosis Program describes how the social and programmatic changes to TB services brought on by COVID-19 have been experienced in practice.
COVID-19 in Africa: community and digital technologies for tuberculosis management
This letter explores the concerns about the negative impact that COVID-19 will have on the fight against tuberculosis in Africa
The Union’s Journal leads the way in published studies on TB and COVID-19
A digital library of tuberculosis and COVID-19 publications has been published by the World Health Organisation (WHO) providing a comprehensive resource for the TB community.A decrease in tuberculosis evaluations and diagnoses during the COVID-19 pandemic
This letter looks at the implications and potential consequences of delayed or missed diagnoses for TB, which may increase TB-related hospitalisations and death.
COVID-19 and tuberculosis—threats and opportunities
In an editorial to the IJTLD, the authors state how we must overcome the challenges that COVID-19 presents and use the opportunities it affords us to achieve a paradigm shift in TB treatment and care
Mexico awarded WNTD prize for achievements in tobacco control
Mexico is recognised on WNTD for its achievements in progressing tobacco controlThe Union welcomes the WHO’s Solidarity Call to Action to realise equitable global access to COVID-19 health technologies
The Union applauds the WHO call to voluntarily pool the knowledge, intellectual property and data necessary for global progress against the COVID-19 pandemic.Severe COVID-19 cases with a history of active or latent tuberculosis
In a letter to the editors, authors report on symptom development, disease progression and treatment for three cases, each representing a different TB scenario.
Common concerns in managing bronchial asthma during the COVID-19 pandemic
A letter to the editors of the IJTLD addresses the major concern of use of corticosteroids and nebulised bronchodilators in bronchial asthma during the COVID-19 pandemic
Message from the Executive Director
Tobacco industry must cease targeting young people in LMICs
Message from the Executive Director, 29 May 2020
On this World No Tobacco Day, we find ourselves in an unprecedented time, in the midst of the COVID-19 pandemic. Though much remains to be determined…
Big Tobacco is denying children and young people the right to be tobacco-free, says Union paper
With around 38 million young people aged 13-15 already using tobacco in its many forms, the specific targeting of youth by the tobacco industry must be addressed immediately.“The tobacco industry is exploiting the COVID-19 pandemic to protect profits and undermine tobacco control policy.”
Emma Green is The Union’s Project Manager for STOP (Stopping Tobacco Organizations and Products), the global tobacco industry watchdog, of which The Union is a partner.Ban e-cigarettes and HTPs in LMICs to prevent a new epidemic of nicotine addiction, says new Union position paper
Ahead of World No Tobacco Day, The Union has today publicly advocated for the prohibition of the sale of e-cigarettes and heated tobacco products in low- and middle-income countriesSTOP finds Big Tobacco front group still spending millions on spin, not science
The Foundation for a Smoke-Free World’s 2019 tax return provides further evidence that it operates primarily as a publicity function of tobacco giant Philip Morris International.The Union backs calls for harmful products including tobacco to be declared non-essential within pandemic responses
Legally binding policies on tobacco control, NCD prevention and responding COVID-19 must be created and implemented for greater transparency, accountability, monitoring and enforcement in order to achieve good health for all.At 73rd World Health Assembly, The Union urges Member States to prioritise TB care and treatment during the pandemic
The Union statement is reproduced here in fullNew devices could transform COVID-19 patient treatment and protect health care workers
Studies on two innovative new devices have been published today by The Union. The development of these devices, a negative pressure procedural tent and a portable helmet device, has the potential to protect healthcare workers and transform the care of COVID-19…
Rapid development of a portable negative pressure procedural tent
A new tent system has been designed to provide healthcare workers separation and protection from exhaled droplets and aerosols, while allowing contact and support for procedures.
Rapid development of a novel portable negative pressure device
A portable, negative pressure environment is one means of confronting these challenges, and could offer benefits to patients, healthcare workers, and institutions alike.
More investment and greater collective efforts needed now if global TB preventive treatment targets are to be met
National TB programmes must plan and launch a systematic and invigorated drive to boost contact investigation, TB Preventative Treatment and treatment for TB.COVID-19 in Africa: preparing for the storm
In response to COVD-19, Africa should develop robust collaborative research programmes, funded by African governments and partners, to include epidemiological, health system, implementation, clinical trials, immunological and virological…
Study shows regimen for short-course preventive therapy for TB for children is valuable alternative
Results from the TITI Study, published in the IIJTLD, demonstrates that a three-month rifampicin-isoniazid (3RH) regimen was found to be a valuable alternative to the six-month isoniazid (6H) regimen for preventing TB in young children.STOP findings expose tobacco industry exploitation of sustainability to improve image and profits
STOP reveals tobacco industry 'greenwashing' tactics - whereby companies engage with sustainability initiatives to distract from their environmentally destructive business activities.